Search Results - "Langen, Karl Josef"

Refine Results
  1. 1
  2. 2
  3. 3

    Relaxometry and quantification in sodium MRI of cerebral gliomas: A FET‐PET and MRI small‐scale study by Worthoff, Wieland A., Shymanskaya, Aliaksandra, Lindemeyer, Johannes, Langen, KarlJosef, Shah, N. Jon

    Published in NMR in biomedicine (01-10-2020)
    “…Sodium MRI is a promising method for assessing the metabolic properties of brain tumours. In a recent study, a strong relationship between semi‐quantitative…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Imaging of sodium in the brain: a brief review by Shah, N. Jon, Worthoff, Wieland A., Langen, Karl-Josef

    Published in NMR in biomedicine (01-02-2016)
    “…Sodium‐based MRI plays a vital role in the study of metabolism and can unveil valuable information about emerging and existing pathology – in particular in the…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors by Werner, Jan-Michael, Lohmann, Philipp, Fink, Gereon R, Langen, Karl-Josef, Galldiks, Norbert

    Published in Molecules (Basel, Switzerland) (24-03-2020)
    “…The number of positron-emission tomography (PET) tracers used to evaluate patients with brain tumors has increased substantially over the last years. For the…”
    Get full text
    Journal Article
  8. 8

    Predicting IDH genotype in gliomas using FET PET radiomics by Lohmann, Philipp, Lerche, Christoph, Bauer, Elena K., Steger, Jan, Stoffels, Gabriele, Blau, Tobias, Dunkl, Veronika, Kocher, Martin, Viswanathan, Shivakumar, Filss, Christian P., Stegmayr, Carina, Ruge, Maximillian I., Neumaier, Bernd, Shah, Nadim J., Fink, Gereon R., Langen, Karl-Josef, Galldiks, Norbert

    Published in Scientific reports (06-09-2018)
    “…Mutations in the isocitrate dehydrogenase (IDH mut) gene have gained paramount importance for the prognosis of glioma patients. To date, reliable techniques…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Use of advanced neuroimaging and artificial intelligence in meningiomas by Galldiks, Norbert, Angenstein, Frank, Werner, Jan‐Michael, Bauer, Elena K., Gutsche, Robin, Fink, Gereon R., Langen, KarlJosef, Lohmann, Philipp

    Published in Brain pathology (Zurich, Switzerland) (01-03-2022)
    “…Anatomical cross‐sectional imaging methods such as contrast‐enhanced MRI and CT are the standard for the delineation, treatment planning, and follow‐up of…”
    Get full text
    Journal Article
  11. 11

    The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy by Galldiks, Norbert, Law, Ian, Pope, Whitney B, Arbizu, Javier, Langen, Karl-Josef

    Published in NeuroImage clinical (01-01-2017)
    “…Routine diagnostics and treatment monitoring of brain tumors is usually based on contrast-enhanced MRI. However, the capacity of conventional MRI to…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Post-stroke treatment with argon preserved neurons and attenuated microglia/macrophage activation long-termly in a rat model of transient middle cerebral artery occlusion (tMCAO) by Liu, Jingjin, Veldeman, Michael, Höllig, Anke, Nolte, Kay, Liebenstund, Lisa, Willuweit, Antje, Langen, Karl-Josef, Rossaint, Rolf, Coburn, Mark

    Published in Scientific reports (13-01-2022)
    “…In a previous study from our group, argon has shown to significantly attenuate brain injury, reduce brain inflammation and enhance M 2 microglia/macrophage…”
    Get full text
    Journal Article
  14. 14

    Investigational PET tracers in neuro-oncology-What's on the horizon? A report of the PET/RANO group by Galldiks, Norbert, Langen, Karl-Josef, Albert, Nathalie L, Law, Ian, Kim, Michelle M, Villanueva-Meyer, Javier E, Soffietti, Riccardo, Wen, Patrick Y, Weller, Michael, Tonn, Joerg C

    Published in Neuro-oncology (Charlottesville, Va.) (02-11-2022)
    “…Many studies in patients with brain tumors evaluating innovative PET tracers have been published in recent years, and the initial results are promising. Here,…”
    Get full text
    Journal Article
  15. 15

    Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis by Lohmann, Philipp, Kocher, Martin, Ceccon, Garry, Bauer, Elena K., Stoffels, Gabriele, Viswanathan, Shivakumar, Ruge, Maximilian I., Neumaier, Bernd, Shah, Nadim J., Fink, Gereon R., Langen, Karl-Josef, Galldiks, Norbert

    Published in NeuroImage clinical (01-01-2018)
    “…The aim of this study was to investigate the potential of combined textural feature analysis of contrast-enhanced MRI (CE-MRI) and static…”
    Get full text
    Journal Article
  16. 16

    Brain Tumors by Herholz, Karl, MD, Langen, Karl-Josef, MD, Schiepers, Christiaan, MD, PhD, Mountz, James M., MD, PhD

    Published in Seminars in nuclear medicine (01-11-2012)
    “…This review addresses the specific contributions of nuclear medicine techniques, and especially positron emission tomography (PET), for diagnosis and…”
    Get full text
    Journal Article
  17. 17

    Role of O -(2- 18 F-Fluoroethyl)-l-Tyrosine PET for Differentiation of Local Recurrent Brain Metastasis from Radiation Necrosis by Galldiks, Norbert, Stoffels, Gabriele, Filss, Christian P., Piroth, Marc D., Sabel, Michael, Ruge, Maximilian I., Herzog, Hans, Shah, Nadim J., Fink, Gereon R., Coenen, Heinz H., Langen, Karl-Josef

    Published in Journal of Nuclear Medicine (01-09-2012)
    “…The aim of this study was to investigate the potential of O-(2-18F-fluoroethyl)-L-tyrosine (18F-FET) PET for differentiating local recurrent brain metastasis…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Amino Acid PET - An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence? by Galldiks, Norbert, Langen, Karl-Josef

    Published in Frontiers in neurology (28-07-2016)
    “…Routine diagnostics and treatment monitoring in patients with primary and secondary brain tumors is usually based on contrast-enhanced standard MRI. However,…”
    Get full text
    Journal Article
  20. 20

    Current trends in the use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) in neurooncology by Stegmayr, Carina, Stoffels, Gabriele, Filß, Christian, Heinzel, Alexander, Lohmann, Philipp, Willuweit, Antje, Ermert, Johannes, Coenen, Heinz H., Mottaghy, Felix M., Galldiks, Norbert, Langen, Karl-Josef

    Published in Nuclear medicine and biology (01-01-2021)
    “…The diagnostic potential of PET using the amino acid analogue O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) in brain tumor diagnostics has been proven in many…”
    Get full text
    Journal Article